Related Experiment Videos
[Effect of livex on hypochromic anemia]
J Nowicka1, M Kuliszkiewicz-Janus, W Fischer
1Kliniki Hematologii AM we Wrocławiu.
Polski Tygodnik Lekarski (Warsaw, Poland : 1960)
|December 17, 1990
Summary
Livex, a bovine blood preparation, effectively treated iron deficiency anemia and related conditions. It significantly improved key blood markers in patients, demonstrating its therapeutic potential.
Area of Science:
- Hematology
- Nutritional Science
- Biochemistry
Context:
- Iron deficiency anemia (IDA) is a prevalent global health issue.
- Lymphoreticular malignancies can complicate iron status.
- Lyophilized bovine blood preparations offer a potential therapeutic avenue.
Purpose:
- To evaluate the efficacy of Livex, a lyophilized bovine blood preparation, in treating iron deficiency anemia (IDA).
- To assess the impact of Livex on patients with lymphoreticular malignancies and associated iron deficiency.
- To determine the effects of Livex on hematological parameters and iron metabolism.
Summary:
- Livex, containing 70% protein and 0.3% iron, was administered at 5g t.i.d. for 3 months to 50 patients (25 with IDA, 25 with lymphoreticular malignancies).
- In IDA patients, primarily women with excessive menstrual bleeding or chronic gastritis, Livex significantly increased hemoglobin, hematocrit, reticulocyte count, mean erythrocyte hemoglobin, serum iron, transferrin saturation, and leukocyte count.
- In patients with lymphoreticular malignancies, Livex therapy led to significant improvements in serum iron, total iron binding capacity, and transferrin saturation.
Impact:
- Livex demonstrates significant therapeutic benefits for iron deficiency anemia, improving multiple hematological indicators.
- The preparation shows promise in managing iron deficiency in patients with complex conditions like lymphoreticular malignancies.
- This study highlights the potential of bovine blood-derived supplements in nutritional and hematological therapies.